Indications and Purposes
| Pentoxifylline Extended-Release Tablets Are Indicated For The Treatment Of Patients With Intermittent Claudication On The Basis Of Chronic Occlusive Arterial Disease Of The Limbs. Pentoxifylline Can Improve Function And Symptoms But Is Not Intended To Replace More Definitive Therapy, Such As Surgical Bypass, Or Removal Of Arterial Obstructions When Treating Peripheral Vascular Disease. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Pentoxifylline |
|
ZINC1530776 |